Luca Fabris

Luca Fabris, MD, PhD, is an Adjunct Professor in the Department of Medicine (Digestive Diseases) at Yale School of Medicine. He holds academic appointments in both Digestive Diseases and Internal Medicine. His research focuses on hepatology, cancer biology, and metabolic disorders, with particular expertise in cholangiocarcinoma, liver fibrosis, and molecular mechanisms of liver diseases.

Education: Dr. Fabris earned his MD from the University of Padova (1987) and PhD from the University of Milan (1997). His work integrates clinical medicine with advanced research methods, including machine learning applications in histology analysis (BiliQML initiative) and molecular biomarker studies.

Research interests span cancer metastasis mechanisms, tumor microenvironment dynamics, and the interplay between liver diseases and cardiovascular complications. Recent studies highlight contributions to understanding SARS-CoV-2 pathophysiology and therapeutic strategies for cholangiocarcinoma and hepatocellular carcinoma.

Collaborations include work with Mario Strazzabosco, MD, PhD, and other international researchers. His publications emphasize translational approaches, bridging basic science discoveries to clinical diagnostics and treatments.